nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—BMPR2—kidney—retroperitoneal cancer	0.00387	0.00387	CbGeAlD
Bosutinib—PLK2—adrenal gland—retroperitoneal cancer	0.00386	0.00386	CbGeAlD
Bosutinib—EIF2AK1—testis—retroperitoneal cancer	0.00385	0.00385	CbGeAlD
Bosutinib—SIK3—adrenal gland—retroperitoneal cancer	0.00383	0.00383	CbGeAlD
Bosutinib—TXK—testis—retroperitoneal cancer	0.00377	0.00377	CbGeAlD
Bosutinib—VRK2—testis—retroperitoneal cancer	0.00373	0.00373	CbGeAlD
Bosutinib—FES—testis—retroperitoneal cancer	0.00373	0.00373	CbGeAlD
Bosutinib—EPHA8—testis—retroperitoneal cancer	0.00373	0.00373	CbGeAlD
Bosutinib—MAP4K4—kidney—retroperitoneal cancer	0.00372	0.00372	CbGeAlD
Bosutinib—STK4—adrenal gland—retroperitoneal cancer	0.00369	0.00369	CbGeAlD
Bosutinib—TNIK—testis—retroperitoneal cancer	0.00366	0.00366	CbGeAlD
Bosutinib—SYK—testis—retroperitoneal cancer	0.00366	0.00366	CbGeAlD
Bosutinib—CAMK1D—adrenal gland—retroperitoneal cancer	0.00365	0.00365	CbGeAlD
Bosutinib—CDK2—testis—retroperitoneal cancer	0.00362	0.00362	CbGeAlD
Bosutinib—STK24—adrenal gland—retroperitoneal cancer	0.0036	0.0036	CbGeAlD
Bosutinib—MAP2K1—kidney—retroperitoneal cancer	0.00359	0.00359	CbGeAlD
Bosutinib—STK26—testis—retroperitoneal cancer	0.00359	0.00359	CbGeAlD
Bosutinib—CSK—kidney—retroperitoneal cancer	0.00357	0.00357	CbGeAlD
Bosutinib—CSNK1A1—kidney—retroperitoneal cancer	0.00355	0.00355	CbGeAlD
Bosutinib—CLK1—kidney—retroperitoneal cancer	0.00352	0.00352	CbGeAlD
Bosutinib—FER—adrenal gland—retroperitoneal cancer	0.00349	0.00349	CbGeAlD
Bosutinib—CHEK2—testis—retroperitoneal cancer	0.00347	0.00347	CbGeAlD
Bosutinib—WEE1—testis—retroperitoneal cancer	0.00344	0.00344	CbGeAlD
Bosutinib—DMPK—testis—retroperitoneal cancer	0.00344	0.00344	CbGeAlD
Bosutinib—LRRK2—kidney—retroperitoneal cancer	0.00343	0.00343	CbGeAlD
Bosutinib—MAP4K1—adrenal gland—retroperitoneal cancer	0.00342	0.00342	CbGeAlD
Bosutinib—BTK—adrenal gland—retroperitoneal cancer	0.0034	0.0034	CbGeAlD
Bosutinib—TNK2—adrenal gland—retroperitoneal cancer	0.00335	0.00335	CbGeAlD
Bosutinib—PTK2B—kidney—retroperitoneal cancer	0.00334	0.00334	CbGeAlD
Bosutinib—MAP4K2—adrenal gland—retroperitoneal cancer	0.0033	0.0033	CbGeAlD
Bosutinib—STK25—testis—retroperitoneal cancer	0.00328	0.00328	CbGeAlD
Bosutinib—STK3—adrenal gland—retroperitoneal cancer	0.00326	0.00326	CbGeAlD
Bosutinib—EPHA3—testis—retroperitoneal cancer	0.00326	0.00326	CbGeAlD
Bosutinib—SIK1—kidney—retroperitoneal cancer	0.00324	0.00324	CbGeAlD
Bosutinib—PLK2—testis—retroperitoneal cancer	0.00319	0.00319	CbGeAlD
Bosutinib—ERBB3—kidney—retroperitoneal cancer	0.00317	0.00317	CbGeAlD
Bosutinib—SIK3—testis—retroperitoneal cancer	0.00317	0.00317	CbGeAlD
Bosutinib—MAP2K2—kidney—retroperitoneal cancer	0.00316	0.00316	CbGeAlD
Bosutinib—BMPR2—adrenal gland—retroperitoneal cancer	0.00312	0.00312	CbGeAlD
Bosutinib—TLK1—lymph node—retroperitoneal cancer	0.00312	0.00312	CbGeAlD
Bosutinib—STK36—adrenal gland—retroperitoneal cancer	0.0031	0.0031	CbGeAlD
Bosutinib—EPHB3—adrenal gland—retroperitoneal cancer	0.0031	0.0031	CbGeAlD
Bosutinib—TBK1—kidney—retroperitoneal cancer	0.00308	0.00308	CbGeAlD
Bosutinib—PTK2—kidney—retroperitoneal cancer	0.00308	0.00308	CbGeAlD
Bosutinib—PRKCQ—lymph node—retroperitoneal cancer	0.00307	0.00307	CbGeAlD
Bosutinib—MERTK—adrenal gland—retroperitoneal cancer	0.00306	0.00306	CbGeAlD
Bosutinib—STK4—testis—retroperitoneal cancer	0.00305	0.00305	CbGeAlD
Bosutinib—CAMK1D—testis—retroperitoneal cancer	0.00302	0.00302	CbGeAlD
Bosutinib—MAP4K4—adrenal gland—retroperitoneal cancer	0.00301	0.00301	CbGeAlD
Bosutinib—NUAK2—adrenal gland—retroperitoneal cancer	0.00299	0.00299	CbGeAlD
Bosutinib—BCR—adrenal gland—retroperitoneal cancer	0.00299	0.00299	CbGeAlD
Bosutinib—STK24—testis—retroperitoneal cancer	0.00298	0.00298	CbGeAlD
Bosutinib—MAP3K12—adrenal gland—retroperitoneal cancer	0.00297	0.00297	CbGeAlD
Bosutinib—RPS6KB1—kidney—retroperitoneal cancer	0.00296	0.00296	CbGeAlD
Bosutinib—MAP2K1—adrenal gland—retroperitoneal cancer	0.00291	0.00291	CbGeAlD
Bosutinib—STK35—adrenal gland—retroperitoneal cancer	0.00291	0.00291	CbGeAlD
Bosutinib—CSK—adrenal gland—retroperitoneal cancer	0.00289	0.00289	CbGeAlD
Bosutinib—FER—testis—retroperitoneal cancer	0.00288	0.00288	CbGeAlD
Bosutinib—TYRO3—testis—retroperitoneal cancer	0.00288	0.00288	CbGeAlD
Bosutinib—ALK—testis—retroperitoneal cancer	0.00288	0.00288	CbGeAlD
Bosutinib—BMX—lymph node—retroperitoneal cancer	0.00288	0.00288	CbGeAlD
Bosutinib—DSTYK—lymph node—retroperitoneal cancer	0.00288	0.00288	CbGeAlD
Bosutinib—CLK3—lymph node—retroperitoneal cancer	0.00288	0.00288	CbGeAlD
Bosutinib—CSNK1A1—adrenal gland—retroperitoneal cancer	0.00287	0.00287	CbGeAlD
Bosutinib—BLK—lymph node—retroperitoneal cancer	0.00285	0.00285	CbGeAlD
Bosutinib—HCK—adrenal gland—retroperitoneal cancer	0.00285	0.00285	CbGeAlD
Bosutinib—CLK1—adrenal gland—retroperitoneal cancer	0.00285	0.00285	CbGeAlD
Bosutinib—ABL2—adrenal gland—retroperitoneal cancer	0.00283	0.00283	CbGeAlD
Bosutinib—MAP4K1—testis—retroperitoneal cancer	0.00283	0.00283	CbGeAlD
Bosutinib—MAP3K19—testis—retroperitoneal cancer	0.00283	0.00283	CbGeAlD
Bosutinib—PHKG1—lymph node—retroperitoneal cancer	0.00282	0.00282	CbGeAlD
Bosutinib—CASK—lymph node—retroperitoneal cancer	0.00282	0.00282	CbGeAlD
Bosutinib—BTK—testis—retroperitoneal cancer	0.00281	0.00281	CbGeAlD
Bosutinib—EPHB4—kidney—retroperitoneal cancer	0.0028	0.0028	CbGeAlD
Bosutinib—CAMK2G—adrenal gland—retroperitoneal cancer	0.0028	0.0028	CbGeAlD
Bosutinib—BMP2K—adrenal gland—retroperitoneal cancer	0.0028	0.0028	CbGeAlD
Bosutinib—EIF2AK1—lymph node—retroperitoneal cancer	0.00279	0.00279	CbGeAlD
Bosutinib—LRRK2—adrenal gland—retroperitoneal cancer	0.00277	0.00277	CbGeAlD
Bosutinib—TNK2—testis—retroperitoneal cancer	0.00277	0.00277	CbGeAlD
Bosutinib—EGFR—adrenal gland—retroperitoneal cancer	0.00276	0.00276	CbGeAlD
Bosutinib—FYN—kidney—retroperitoneal cancer	0.00274	0.00274	CbGeAlD
Bosutinib—MAP4K2—testis—retroperitoneal cancer	0.00273	0.00273	CbGeAlD
Bosutinib—TXK—lymph node—retroperitoneal cancer	0.00273	0.00273	CbGeAlD
Bosutinib—VRK2—lymph node—retroperitoneal cancer	0.0027	0.0027	CbGeAlD
Bosutinib—FES—lymph node—retroperitoneal cancer	0.0027	0.0027	CbGeAlD
Bosutinib—PTK2B—adrenal gland—retroperitoneal cancer	0.0027	0.0027	CbGeAlD
Bosutinib—ERBB4—testis—retroperitoneal cancer	0.0027	0.0027	CbGeAlD
Bosutinib—STK3—testis—retroperitoneal cancer	0.0027	0.0027	CbGeAlD
Bosutinib—ROCK1—testis—retroperitoneal cancer	0.00266	0.00266	CbGeAlD
Bosutinib—CSNK1E—adrenal gland—retroperitoneal cancer	0.00266	0.00266	CbGeAlD
Bosutinib—SYK—lymph node—retroperitoneal cancer	0.00265	0.00265	CbGeAlD
Bosutinib—TNIK—lymph node—retroperitoneal cancer	0.00265	0.00265	CbGeAlD
Bosutinib—CDK2—lymph node—retroperitoneal cancer	0.00263	0.00263	CbGeAlD
Bosutinib—IRAK4—adrenal gland—retroperitoneal cancer	0.00262	0.00262	CbGeAlD
Bosutinib—SIK1—adrenal gland—retroperitoneal cancer	0.00262	0.00262	CbGeAlD
Bosutinib—STK26—lymph node—retroperitoneal cancer	0.0026	0.0026	CbGeAlD
Bosutinib—EPHA4—adrenal gland—retroperitoneal cancer	0.00259	0.00259	CbGeAlD
Bosutinib—BMPR2—testis—retroperitoneal cancer	0.00258	0.00258	CbGeAlD
Bosutinib—STK36—testis—retroperitoneal cancer	0.00256	0.00256	CbGeAlD
Bosutinib—EPHB3—testis—retroperitoneal cancer	0.00256	0.00256	CbGeAlD
Bosutinib—MAP2K2—adrenal gland—retroperitoneal cancer	0.00256	0.00256	CbGeAlD
Bosutinib—ULK3—adrenal gland—retroperitoneal cancer	0.00256	0.00256	CbGeAlD
Bosutinib—MAP3K2—adrenal gland—retroperitoneal cancer	0.00254	0.00254	CbGeAlD
Bosutinib—MERTK—testis—retroperitoneal cancer	0.00253	0.00253	CbGeAlD
Bosutinib—MAP3K7—adrenal gland—retroperitoneal cancer	0.00252	0.00252	CbGeAlD
Bosutinib—CHEK2—lymph node—retroperitoneal cancer	0.00251	0.00251	CbGeAlD
Bosutinib—DMPK—lymph node—retroperitoneal cancer	0.00249	0.00249	CbGeAlD
Bosutinib—WEE1—lymph node—retroperitoneal cancer	0.00249	0.00249	CbGeAlD
Bosutinib—MAP4K4—testis—retroperitoneal cancer	0.00249	0.00249	CbGeAlD
Bosutinib—TBK1—adrenal gland—retroperitoneal cancer	0.00249	0.00249	CbGeAlD
Bosutinib—PTK2—adrenal gland—retroperitoneal cancer	0.00249	0.00249	CbGeAlD
Bosutinib—YES1—kidney—retroperitoneal cancer	0.00247	0.00247	CbGeAlD
Bosutinib—NUAK2—testis—retroperitoneal cancer	0.00247	0.00247	CbGeAlD
Bosutinib—BCR—testis—retroperitoneal cancer	0.00247	0.00247	CbGeAlD
Bosutinib—MAP3K12—testis—retroperitoneal cancer	0.00245	0.00245	CbGeAlD
Bosutinib—STK10—kidney—retroperitoneal cancer	0.00245	0.00245	CbGeAlD
Bosutinib—TAOK3—kidney—retroperitoneal cancer	0.00244	0.00244	CbGeAlD
Bosutinib—IRAK1—adrenal gland—retroperitoneal cancer	0.00244	0.00244	CbGeAlD
Bosutinib—MAP2K1—testis—retroperitoneal cancer	0.0024	0.0024	CbGeAlD
Bosutinib—STK35—testis—retroperitoneal cancer	0.0024	0.0024	CbGeAlD
Bosutinib—RPS6KB1—adrenal gland—retroperitoneal cancer	0.00239	0.00239	CbGeAlD
Bosutinib—CSK—testis—retroperitoneal cancer	0.00239	0.00239	CbGeAlD
Bosutinib—SRC—kidney—retroperitoneal cancer	0.00238	0.00238	CbGeAlD
Bosutinib—STK25—lymph node—retroperitoneal cancer	0.00238	0.00238	CbGeAlD
Bosutinib—LCK—adrenal gland—retroperitoneal cancer	0.00238	0.00238	CbGeAlD
Bosutinib—FGR—adrenal gland—retroperitoneal cancer	0.00238	0.00238	CbGeAlD
Bosutinib—CSNK1A1—testis—retroperitoneal cancer	0.00237	0.00237	CbGeAlD
Bosutinib—AXL—adrenal gland—retroperitoneal cancer	0.00237	0.00237	CbGeAlD
Bosutinib—EPHA3—lymph node—retroperitoneal cancer	0.00236	0.00236	CbGeAlD
Bosutinib—CLK1—testis—retroperitoneal cancer	0.00236	0.00236	CbGeAlD
Bosutinib—HCK—testis—retroperitoneal cancer	0.00236	0.00236	CbGeAlD
Bosutinib—ABL2—testis—retroperitoneal cancer	0.00234	0.00234	CbGeAlD
Bosutinib—PLK2—lymph node—retroperitoneal cancer	0.00231	0.00231	CbGeAlD
Bosutinib—BMP2K—testis—retroperitoneal cancer	0.00231	0.00231	CbGeAlD
Bosutinib—CAMK2G—testis—retroperitoneal cancer	0.00231	0.00231	CbGeAlD
Bosutinib—SIK3—lymph node—retroperitoneal cancer	0.0023	0.0023	CbGeAlD
Bosutinib—LRRK2—testis—retroperitoneal cancer	0.00229	0.00229	CbGeAlD
Bosutinib—EGFR—testis—retroperitoneal cancer	0.00229	0.00229	CbGeAlD
Bosutinib—SLK—adrenal gland—retroperitoneal cancer	0.00228	0.00228	CbGeAlD
Bosutinib—EPHB4—adrenal gland—retroperitoneal cancer	0.00226	0.00226	CbGeAlD
Bosutinib—PTK2B—testis—retroperitoneal cancer	0.00223	0.00223	CbGeAlD
Bosutinib—EPHA2—adrenal gland—retroperitoneal cancer	0.00222	0.00222	CbGeAlD
Bosutinib—FYN—adrenal gland—retroperitoneal cancer	0.00222	0.00222	CbGeAlD
Bosutinib—STK4—lymph node—retroperitoneal cancer	0.00221	0.00221	CbGeAlD
Bosutinib—CSNK1E—testis—retroperitoneal cancer	0.0022	0.0022	CbGeAlD
Bosutinib—CAMK1D—lymph node—retroperitoneal cancer	0.00219	0.00219	CbGeAlD
Bosutinib—MAP4K5—adrenal gland—retroperitoneal cancer	0.00217	0.00217	CbGeAlD
Bosutinib—MAP3K3—adrenal gland—retroperitoneal cancer	0.00217	0.00217	CbGeAlD
Bosutinib—SIK1—testis—retroperitoneal cancer	0.00216	0.00216	CbGeAlD
Bosutinib—IRAK4—testis—retroperitoneal cancer	0.00216	0.00216	CbGeAlD
Bosutinib—STK24—lymph node—retroperitoneal cancer	0.00216	0.00216	CbGeAlD
Bosutinib—EPHA4—testis—retroperitoneal cancer	0.00214	0.00214	CbGeAlD
Bosutinib—ERBB3—testis—retroperitoneal cancer	0.00212	0.00212	CbGeAlD
Bosutinib—ULK3—testis—retroperitoneal cancer	0.00212	0.00212	CbGeAlD
Bosutinib—MAP2K2—testis—retroperitoneal cancer	0.00212	0.00212	CbGeAlD
Bosutinib—MAP3K2—testis—retroperitoneal cancer	0.0021	0.0021	CbGeAlD
Bosutinib—ALK—lymph node—retroperitoneal cancer	0.00209	0.00209	CbGeAlD
Bosutinib—FER—lymph node—retroperitoneal cancer	0.00209	0.00209	CbGeAlD
Bosutinib—MAP3K7—testis—retroperitoneal cancer	0.00208	0.00208	CbGeAlD
Bosutinib—PTK2—testis—retroperitoneal cancer	0.00206	0.00206	CbGeAlD
Bosutinib—TBK1—testis—retroperitoneal cancer	0.00206	0.00206	CbGeAlD
Bosutinib—MAP4K1—lymph node—retroperitoneal cancer	0.00205	0.00205	CbGeAlD
Bosutinib—BTK—lymph node—retroperitoneal cancer	0.00204	0.00204	CbGeAlD
Bosutinib—IRAK1—testis—retroperitoneal cancer	0.00202	0.00202	CbGeAlD
Bosutinib—TNK2—lymph node—retroperitoneal cancer	0.00201	0.00201	CbGeAlD
Bosutinib—YES1—adrenal gland—retroperitoneal cancer	0.002	0.002	CbGeAlD
Bosutinib—STK10—adrenal gland—retroperitoneal cancer	0.00198	0.00198	CbGeAlD
Bosutinib—MAP4K2—lymph node—retroperitoneal cancer	0.00198	0.00198	CbGeAlD
Bosutinib—RPS6KB1—testis—retroperitoneal cancer	0.00198	0.00198	CbGeAlD
Bosutinib—TAOK3—adrenal gland—retroperitoneal cancer	0.00197	0.00197	CbGeAlD
Bosutinib—FGR—testis—retroperitoneal cancer	0.00197	0.00197	CbGeAlD
Bosutinib—LCK—testis—retroperitoneal cancer	0.00197	0.00197	CbGeAlD
Bosutinib—AXL—testis—retroperitoneal cancer	0.00196	0.00196	CbGeAlD
Bosutinib—STK3—lymph node—retroperitoneal cancer	0.00195	0.00195	CbGeAlD
Bosutinib—SRC—adrenal gland—retroperitoneal cancer	0.00192	0.00192	CbGeAlD
Bosutinib—PDGFRB—kidney—retroperitoneal cancer	0.0019	0.0019	CbGeAlD
Bosutinib—SLK—testis—retroperitoneal cancer	0.00189	0.00189	CbGeAlD
Bosutinib—BMPR2—lymph node—retroperitoneal cancer	0.00187	0.00187	CbGeAlD
Bosutinib—EPHB4—testis—retroperitoneal cancer	0.00187	0.00187	CbGeAlD
Bosutinib—STK36—lymph node—retroperitoneal cancer	0.00186	0.00186	CbGeAlD
Bosutinib—EPHB3—lymph node—retroperitoneal cancer	0.00186	0.00186	CbGeAlD
Bosutinib—MERTK—lymph node—retroperitoneal cancer	0.00184	0.00184	CbGeAlD
Bosutinib—EPHA2—testis—retroperitoneal cancer	0.00184	0.00184	CbGeAlD
Bosutinib—FYN—testis—retroperitoneal cancer	0.00183	0.00183	CbGeAlD
Bosutinib—MAP4K4—lymph node—retroperitoneal cancer	0.0018	0.0018	CbGeAlD
Bosutinib—MAP3K3—testis—retroperitoneal cancer	0.00179	0.00179	CbGeAlD
Bosutinib—MAP4K5—testis—retroperitoneal cancer	0.00179	0.00179	CbGeAlD
Bosutinib—BCR—lymph node—retroperitoneal cancer	0.00179	0.00179	CbGeAlD
Bosutinib—NUAK2—lymph node—retroperitoneal cancer	0.00179	0.00179	CbGeAlD
Bosutinib—MAP3K12—lymph node—retroperitoneal cancer	0.00178	0.00178	CbGeAlD
Bosutinib—MAP2K5—adrenal gland—retroperitoneal cancer	0.00177	0.00177	CbGeAlD
Bosutinib—MAP2K1—lymph node—retroperitoneal cancer	0.00174	0.00174	CbGeAlD
Bosutinib—STK35—lymph node—retroperitoneal cancer	0.00174	0.00174	CbGeAlD
Bosutinib—CSK—lymph node—retroperitoneal cancer	0.00173	0.00173	CbGeAlD
Bosutinib—CSF1R—adrenal gland—retroperitoneal cancer	0.00173	0.00173	CbGeAlD
Bosutinib—CSNK1A1—lymph node—retroperitoneal cancer	0.00172	0.00172	CbGeAlD
Bosutinib—HCK—lymph node—retroperitoneal cancer	0.00171	0.00171	CbGeAlD
Bosutinib—CLK1—lymph node—retroperitoneal cancer	0.00171	0.00171	CbGeAlD
Bosutinib—ABL2—lymph node—retroperitoneal cancer	0.0017	0.0017	CbGeAlD
Bosutinib—ABL1—kidney—retroperitoneal cancer	0.00169	0.00169	CbGeAlD
Bosutinib—BMP2K—lymph node—retroperitoneal cancer	0.00168	0.00168	CbGeAlD
Bosutinib—CAMK2G—lymph node—retroperitoneal cancer	0.00168	0.00168	CbGeAlD
Bosutinib—LRRK2—lymph node—retroperitoneal cancer	0.00166	0.00166	CbGeAlD
Bosutinib—EGFR—lymph node—retroperitoneal cancer	0.00166	0.00166	CbGeAlD
Bosutinib—YES1—testis—retroperitoneal cancer	0.00165	0.00165	CbGeAlD
Bosutinib—STK10—testis—retroperitoneal cancer	0.00164	0.00164	CbGeAlD
Bosutinib—TAOK3—testis—retroperitoneal cancer	0.00163	0.00163	CbGeAlD
Bosutinib—PTK2B—lymph node—retroperitoneal cancer	0.00162	0.00162	CbGeAlD
Bosutinib—CSNK1E—lymph node—retroperitoneal cancer	0.00159	0.00159	CbGeAlD
Bosutinib—SRC—testis—retroperitoneal cancer	0.00159	0.00159	CbGeAlD
Bosutinib—SIK1—lymph node—retroperitoneal cancer	0.00157	0.00157	CbGeAlD
Bosutinib—IRAK4—lymph node—retroperitoneal cancer	0.00157	0.00157	CbGeAlD
Bosutinib—EPHA4—lymph node—retroperitoneal cancer	0.00155	0.00155	CbGeAlD
Bosutinib—ERBB3—lymph node—retroperitoneal cancer	0.00154	0.00154	CbGeAlD
Bosutinib—ULK3—lymph node—retroperitoneal cancer	0.00153	0.00153	CbGeAlD
Bosutinib—MAP2K2—lymph node—retroperitoneal cancer	0.00153	0.00153	CbGeAlD
Bosutinib—PDGFRB—adrenal gland—retroperitoneal cancer	0.00153	0.00153	CbGeAlD
Bosutinib—MAP3K2—lymph node—retroperitoneal cancer	0.00152	0.00152	CbGeAlD
Bosutinib—MAP3K7—lymph node—retroperitoneal cancer	0.00151	0.00151	CbGeAlD
Bosutinib—PTK2—lymph node—retroperitoneal cancer	0.00149	0.00149	CbGeAlD
Bosutinib—TBK1—lymph node—retroperitoneal cancer	0.00149	0.00149	CbGeAlD
Bosutinib—MAP2K5—testis—retroperitoneal cancer	0.00146	0.00146	CbGeAlD
Bosutinib—IRAK1—lymph node—retroperitoneal cancer	0.00146	0.00146	CbGeAlD
Bosutinib—RPS6KB1—lymph node—retroperitoneal cancer	0.00143	0.00143	CbGeAlD
Bosutinib—CSF1R—testis—retroperitoneal cancer	0.00143	0.00143	CbGeAlD
Bosutinib—FGR—lymph node—retroperitoneal cancer	0.00143	0.00143	CbGeAlD
Bosutinib—LCK—lymph node—retroperitoneal cancer	0.00143	0.00143	CbGeAlD
Bosutinib—AXL—lymph node—retroperitoneal cancer	0.00142	0.00142	CbGeAlD
Bosutinib—SLK—lymph node—retroperitoneal cancer	0.00137	0.00137	CbGeAlD
Bosutinib—ABL1—adrenal gland—retroperitoneal cancer	0.00137	0.00137	CbGeAlD
Bosutinib—EPHB4—lymph node—retroperitoneal cancer	0.00136	0.00136	CbGeAlD
Bosutinib—EPHA2—lymph node—retroperitoneal cancer	0.00133	0.00133	CbGeAlD
Bosutinib—FYN—lymph node—retroperitoneal cancer	0.00133	0.00133	CbGeAlD
Bosutinib—MAP3K3—lymph node—retroperitoneal cancer	0.0013	0.0013	CbGeAlD
Bosutinib—MAP4K5—lymph node—retroperitoneal cancer	0.0013	0.0013	CbGeAlD
Bosutinib—PDGFRB—testis—retroperitoneal cancer	0.00127	0.00127	CbGeAlD
Bosutinib—YES1—lymph node—retroperitoneal cancer	0.0012	0.0012	CbGeAlD
Bosutinib—STK10—lymph node—retroperitoneal cancer	0.00119	0.00119	CbGeAlD
Bosutinib—TAOK3—lymph node—retroperitoneal cancer	0.00118	0.00118	CbGeAlD
Bosutinib—SRC—lymph node—retroperitoneal cancer	0.00115	0.00115	CbGeAlD
Bosutinib—ABL1—testis—retroperitoneal cancer	0.00113	0.00113	CbGeAlD
Bosutinib—MAP2K5—lymph node—retroperitoneal cancer	0.00106	0.00106	CbGeAlD
Bosutinib—CSF1R—lymph node—retroperitoneal cancer	0.00104	0.00104	CbGeAlD
Bosutinib—PDGFRB—lymph node—retroperitoneal cancer	0.000918	0.000918	CbGeAlD
Bosutinib—ABL1—lymph node—retroperitoneal cancer	0.000819	0.000819	CbGeAlD
Bosutinib—CYP3A4—kidney—retroperitoneal cancer	0.000742	0.000742	CbGeAlD
Bosutinib—ABCB1—kidney—retroperitoneal cancer	0.000525	0.000525	CbGeAlD
Bosutinib—ABCB1—adrenal gland—retroperitoneal cancer	0.000425	0.000425	CbGeAlD
Bosutinib—ABCB1—testis—retroperitoneal cancer	0.000351	0.000351	CbGeAlD
Bosutinib—ABCB1—lymph node—retroperitoneal cancer	0.000255	0.000255	CbGeAlD
